Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study.
Donnelly DW, Vis LC, Kearney T, Sharp L, Bennett D, Wilding S, Downing A, Wright P, Watson E, Wagland R, Cross WR, Mason MD, Siesling S, van Manen JG, Glaser AW, Gavin A.
Donnelly DW, et al. Among authors: van manen jg.
BMC Cancer. 2019 Oct 15;19(1):947. doi: 10.1186/s12885-019-6164-5.
BMC Cancer. 2019.
PMID: 31615476
Free PMC article.